IP Library › Granted Patent US 11,896,523
Granted Patent B2
US 11,896,523 · App. 17/946,644 · Granted Feb 13, 2024

Devices and methods for targeted delivery of a substance

Inventors: John S. Pollack (Naperville, IL); William R. Voss (Hinsdale, IL)
Assignee: Sanulus Medical, LLC
A61F9/00727A61B17/00491A61B2017/00336A61B2017/00951
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,896,523
App. No.
17/946,644
Granted
Feb 13, 2024
Kind
B2
Abstract

Devices, systems and methods for applying a bioadhesive substance to an internal surface of the eye, such as the retina, can include an outer sleeve having a proximal end, a distal end, a passageway extending along a length of the elongate body and an opening at the distal end of the elongate body, an applicator tip including an elongate body having a proximal end and a distal end, an applicator portion coupled with the distal end of the elongate body, and a substance supply lumen extending along a length of the device through which a bioadhesive substance can pass so that the bioadhesive substance can be applied to at least the applicator portion of the applicator tip. Some embodiments of the device can also have a source of the bioadhesive substance in fluid communication with at least the substance supply lumen.

Claims (23)

1. A method of treating eye tissue, comprising:

advancing a device into an eye;

contacting a surface of the eye with a bioadhesive substance on the device, the bioadhesive substance on the device being in the form of a bubble wherein the bioadhesive substance surrounds a gas;

transferring the bioadhesive substance from the device to the surface of the eye without the application of a patch such that the bioadhesive substance covers an entirety of the eye tissue within a retinal defect.

2. The method of claim 1 , further comprising overlapping intact retinal tissue in a margin adjacent a border of the retinal defect with the bioadhesive substance.

3. The method of claim 1 , wherein the bioadhesive substance is applied to retinal tissue within the retinal defect.

4. The method of claim 3 , wherein the bioadhesive substance is applied to bare intact sclera tissue within the retinal defect.

5. The method of claim 1 , wherein the bioadhesive substance is applied to bare intact sclera tissue within the retinal defect.

6. The method of claim 1 , further comprising brushing the bubble against the surface of the eye.

7. The method of claim 1 , further comprising pressing the bubble into contact with the surface of the eye.

8. The method of claim 1 , wherein the device is configured for use in any orientation.

9. The method of claim 1 , wherein the bioadhesive substance on the device when the bioadhesive substance contacts the surface of the eye has a larger profile than the device when the device is configured for advancement into the eye.

10. The method of claim 1 , wherein the bioadhesive substance completely surrounds the gas.

11. The method of claim 1 , wherein the gas comprises air.

12. The method of claim 1 , wherein the bubble is formed by applying a layer of the bioadhesive substance onto a distal end of the device.

13. The method of claim 12 , further comprising introducing the bioadhesive substance to the distal end of the device through a bioadhesive pathway defined by the device.

14. The method of claim 12 , wherein the layer of the bioadhesive substance is applied onto a rim at the distal end of the device, the rim having a flat, circumferential face.

15. The method of claim 14 , further comprising introducing the gas through an exit port circumvented by the rim.

16. The method of claim 15 , wherein the bioadhesive substance covers the exit port.

17. The method of claim 12 , further comprising introducing the gas to the layer of the bioadhesive substance.

18. The method of claim 17 , further comprising introducing the gas through an expansion gas passageway defined by the device.

19. The method of claim 1 , further comprising introducing the bioadhesive substance through a bioadhesive pathway defined by the device, and introducing the gas through an expansion gas passageway defined by the device, the expansion gas passageway being separate from the bioadhesive pathway.

20. The method of claim 19 , wherein the bioadhesive pathway surrounds the expansion gas passageway.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2023
From: POLLACK, JOHN S.; VOSS, WILLIAM R.
To: SANULUS MEDICAL, LLC
Reel/Frame 062751/0744 →
Continuity (10)
Continuation In Part 17866111 · Jul 15, 2022
Continuation In Part 17739585 · May 9, 2022
Continuation In Part 17368551 · Jul 6, 2021
Continuation 16516112 · Jul 18, 2019
Continuation In Part 16516112 · Jul 18, 2019
Provisional Application 63050695 · Jul 10, 2020
Provisional Application 63049044 · Jul 7, 2020
Provisional Application 62796338 · Jan 24, 2019
Provisional Application 62700768 · Jul 19, 2018
Related Publication 20230018481A1 · Jan 19, 2023
Cited By (1)
US 12,589,029